Thyroid Gland Disorders Treatment Market by Disorder Treatment Types (Hyperthyroidism – Imidazole, Propacil, and Hypothyroidism – Levothyroxine, Liothyronine) and Forecast 2017-2021

Thyroid Gland Disorders Treatment Market by Disorder Treatment Types (Hyperthyroidism – Imidazole, Propacil, and Hypothyroidism – Levothyroxine, Liothyronine) and Forecast 2017-2021

The thyroid gland manufactures hormones that regulate the body’s metabolism (the process of creating and using energy). There are several different disorders that can arise when the thyroid produces too much hormone (hyperthyroidism) or not enough (hypothyroidism). Four common thyroid disorders include Hashimoto’s disease, Graves’ disease, goiter, and thyroid nodules. The most serious form of hypothyroidism is called myxedema, which can lead to coma and even death. An underactive thyroid gland affects all organs and functions within the body, leading to both physical and emotional symptoms. Thyroid gland is prone to several distinct problems including underactive thyroid (hypothyroidism), overactive thyroid (hyperthyroidism), and thyroid nodules, autoimmune thyroiditis (Hashimoto’s thyroiditis), where hypothyroidism and hyperthyroidism are the most common disorders. Several therapeutic drugs are commercially available for these disorders. Hormone replacement drugs such as synthetic long acting thyroid hormones, levothyroxine and liothyronine are used for hypothyroidism, whereas hyperthyroidism is treated through therapeutics such as imidazole and propacil.

The global thyroid gland disorders treatment market report estimates the market size (Revenue USD million – 2014 to 2021) for key market segments based on the disorder treatment types (hyperthyroidism – imidazole, propacil, and hypothyroidism – levothyroxine, liothyronine), and forecasts growth trends (CAGR% – 2017 to 2021).

The global thyroid gland disorders treatment market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global thyroid gland disorders treatment market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global thyroid gland disorders treatment market and included in this report are AbbVie, Inc., Allergan plc, and Pfizer, Inc.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Drugs
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Drug Class or Drug (Brand) Type
    • Drug or Disorder Test
    • Indication Type
    • Drug Treatment
    • Mechanism of Action
    • Therapeutic Area or Nature of Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • IND, NDA filed, FDA, EMEA Approvals
  8. Pipeline Analysis(Phase 1, 2 and 3 Drugs)
    • Phase 3 Drugs Forecast Estimation (Approval to 2025)
    • Phase 1 and 2 Drugs – Qualitative Analysis
  9. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  10. Recommendations
  11. References

Thyroid Gland Disorders Treatment Market

1. Disorder Type
1.1. Hyperthyroidism
1.2. Hypothyroidism
1.3. Imidazole
1.4. Levothyroxine
1.5. Liothyronine
1.6. Propacil

2. Company Profiles
2.1. Abbott Laboratories
2.2. AbbVie, Inc.
2.3. Allergan plc
2.4. GlaxoSmithKline plc
2.5. Lannett Company, Inc.
2.6. Merck KGaA
2.7. Mylan N.V.
2.8. Novartis International AG
2.9. Pfizer, Inc.
2.10. Sanofi SA
2.11. Takeda Pharmaceutical Co., Ltd.

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*